Global Blood Therapeutics (NASDAQ:GBT) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Global Blood Therapeutics missed estimated earnings by 20.35%, reporting an EPS of $-1.36 versus an estimate of $-1.13.
Revenue was up $14.80 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 10.21% drop in the share price the next day.
Here's a look at Global Blood Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -1.11 | -1.19 | -1.01 | -0.94 |
| EPS Actual | -1.13 | -1.12 | -1.21 | -1 |
| Revenue Estimate | 53.70M | 43.84M | 43.00M | 39.03M |
| Revenue Actual | 52.05M | 47.55M | 39.04M | 41.30M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
